Supplement 1. eFigure 1. Inclusion and Exclusion Criteria of the Three OAC Cohorts (i.e. Warfarin, Apixaban and Rivaroxaban Users vs Non-Users Cohorts) among Long-term Nursing Home Residents With Atrial Fibrillation and ADL Disability eFigure 2. Cumulative Incidence Function for Major Bleeding Comparing Apixaban Users and Matched Non-users, Accounting for the Competing Risk of Death eTable 1. Target Trial Emulation Table eTable 2.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Daniel E.
Contact Daniel E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack